Insider buying last 90 days
No open-market insider purchases were filed for MPT in the last 90 days.
From Form 4 filings, dated to when each was filed.
Oct 12 close
Medical Properties Trust touches a fresh 52-week low this week, falling to $3.10 even as short interest climbs to 32.76% of the float, equal to 146,186,806 shares and roughly 11.81 days to cover. Alongside the decline, the company's Q2 2026 revenue of $259.28 million exceeded expectations despite a small loss per share, and commentary points to a 0.42 times book value multiple, an oversold RSI reading, and an 11.29% dividend yield. Several executives, including the CEO, had shares withheld on October 7 to cover taxes on vesting restricted stock, transactions explicitly described as not sales.
MPT closes at $3.14, below both its 50-day average of $3.84 and 200-day average of $4.73, with the 50-day itself below the 200-day, reflecting a one-year return of -40.2% and a six-month return of -36.4%. The GekkoIndex reads 68.5, placing the stock in the Accumulation zone. Price sits 28% below Gekko Fair Value of $4.36.
Earnings are scheduled for 29 October, 16 days out and inside a typical 20-trading-day holding window; the last report showed an EPS miss of -$0.01 against a $0.01 estimate, with a -14.5% reaction. No insider, Congress, or unusual options activity appears in the respective 90-day and 30-day windows. Seasonality over five years shows a -1% average 20-day return from this point, rising in 2 of those years. Analyst views remain split, with 6 firms covering the stock, 2 at buy and 3 at sell, and a consensus target of $5.12.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
Medical Properties Trust scores 2 supportive, 0 mixed and 3 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive0 mixed3 headwinds
Below 50 and 200-day
Close $3.14 is below the 50-day ($3.84) and 200-day ($4.73) averages, and the 50-day is below the 200-day.
See the chart68.5, Accumulation
Reading 68.5 is in the Accumulation zone.
See the GekkoIndex28.0% below
Price is 28% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 17 days
Reports on Oct 29, 2026, 17 days away — inside a typical 20-trading-day hold.
See earnings−1.0% on average
From this point in the calendar, the next 20 trading days averaged −1% over 5 years, rising in 2 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Medical Properties Trust closed at $3.14 on Oct 12, 2026, −40.2% over the past year, inside a 52-week range of $3.05 to $6.47.
Use the left and right arrow keys to read daily values.
Put MPT on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Medical Properties Trust owns healthcare real estate, putting money into financing, buying, and building facilities that it then leases out under net-lease arrangements. Its portfolio spans a wide mix of care settings, including rehabilitation centers, long-term acute care hospitals, outpatient surgery centers, hospitals focused on women's and children's health, general community hospitals, and medical office buildings, among other specialized treatment sites.
The trust runs as a self-managed REIT, meaning it handles its own property and investment decisions rather than outsourcing that work to an external manager. Its income comes from the rent and financing arrangements tied to the healthcare operators that use its properties.
Medical Properties Trust traces back to its founding in 2003 by Edward K. Aldag Jr., R. Steven Hamner, Emmett E. McLean, and William Gilliard McKenzie, and it keeps its headquarters in Birmingham, Alabama. Its shares trade under the ticker MPT.
Medical Properties Trust’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 68.5, in the Accumulation zone, up 1.5 points over five sessions.
Up 1.5 points over five sessions.
Reading for Oct 12, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 96 | +1.1% | +2.3% | ||
| Accumulation (current zone) | 224 | −0.6% | 0.0% | ||
| Neutral | 257 | +0.5% | −0.1% | ||
| Distribution | 52 | −1.8% | −1.8% | ||
| Selling | 6 | Too few readings yet | |||
Average MPT share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.2% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
Medical Properties Trust trades 28.0% below Gekko Fair Value of $4.36, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Medical Properties Trust shares are worth, recalculated every trading day.
$4.36
Gekko Fair Value, Oct 10, 2026
28.0% Undervalued
At the end of Aug 2026 the price was 18.8% below the estimate.
No open-market insider purchases were filed for Medical Properties Trust, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for MPT in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in MPT were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Medical Properties Trust has been buying back its own shares.
From company filings.
1of the funds Gekko tracks holds MPT.
Medical Properties Trust reports on Oct 29, 2026, before the open (17 days away), and beat the EPS estimate in 2 of its last 8 reports.
Oct 29, 2026
Expected before the open, 17 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 10, 2026 | −$0.01 est $0.01 | $259.3M est $247.3M | −14.5% |
| Apr 30, 2026 | $0.05 est $0.03 | $252.1M est $241.6M | −1.6% |
| Feb 19, 2026 | $0.03 est $0.02 | $270.3M est $240.4M | +5.4% |
| Oct 30, 2025 | −$0.13 est $0.02 | $237.5M est $244.0M | +6.4% |
| Jul 31, 2025 | −$0.16 est $0.02 | $240.4M est $244.7M | −1.7% |
| May 1, 2025 | −$0.20 est −$0.01 | $223.8M est $240.0M | −5.1% |
| Feb 27, 2025 | −$0.69 est −$0.06 | $235.3M est $233.1M | +23.7% |
| Nov 7, 2024 | −$0.09 est $0.10 | $225.8M est $228.8M | +7.0% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Medical Properties Trust is $5.12, +63.1% from the last close, from 6 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 6 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 18 | J.P. Morgan | — | — |
| Sep 17 | KeyBanc | — | — |
| Sep 1 | Wells Fargo | $3.80 | +21.0% |
| Aug 17 | Bank of America Securities | $4.25 | +35.4% |
| Aug 12 | Colliers Securities | $5 | +59.2% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Oct 10, Medical Properties Trust averaged −1.0% across the last 5 years, rising in 2 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −0.6% | 2 of 5 |
| Next 10 trading days | −3.9% | 1 of 5 |
| Next 15 trading days | −0.2% | 3 of 5 |
| Next 20 trading days | −1.0% | 2 of 5 |
| Next 30 trading days | −0.4% | 3 of 5 |
For scale, MPT’s typical 20-trading-day move in either direction is about 9.3%.
Medical Properties Trust’s market cap is $1.88B and revenue of $1.10B over the last twelve months.
Coverage of Medical Properties Trust this week reads negative: 1 positive, 5 neutral and 5 negative headlines.
Medical Properties Trust’s market cap is $1.88B at the Oct 12, 2026 close of $3.14, with 597.2M shares outstanding.
The consensus analyst 12-month price target for Medical Properties Trust is $5.12, +63.1% from the last close. Of the 6 firms that rated the stock in the last 90 days, 2 rate it a buy, 1 a hold and 3 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Medical Properties Trust is undervalued: the Oct 12, 2026 close of $3.14 is 28.0% below Gekko Fair Value of $4.36. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Medical Properties Trust is expected to report on Oct 29, 2026, before the market opens (17 days away). Analysts expect earnings of −$0.01 per share on revenue of $256.9M. Medical Properties Trust beat the earnings estimate in 2 of its last 8 reports, moving 8.2% on average across the report.
Medical Properties Trust’s 52-week high is $6.47 and its 52-week low is $3.05; it closed at $3.14 on Oct 12, 2026, −40.2% over the past year. Over the last five years the shares peaked at $24.13 on Jan 14, 2022.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (gekkoindex and fair value) and 3 as headwinds (trend, earnings risk and seasonality). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.